A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot

Conclusion Pilot data indicate preliminary demonstration of feasibility and acceptability of a fully digital pathway for BRCA-testing and support proceeding to a full powered study for evaluation of non-inferiority of the fully digital pathway, detailed quantitative assessment of outcomes and operational economic analyses. Trial registration number ISRCTN87845055.

http://jmg.bmj.com/cgi/content/short/59/12/1179?rss=1

Source: Journal of Medical Genetics - November 22, 2022 Category: Genetics & Stem Cells Authors: Torr, B., Jones, C., Choi, S., Allen, S., Kavanaugh, G., Hamill, M., Garrett, A., MacMahon, S., Loong, L., Reay, A., Yuan, L., Valganon Petrizan, M., Monson, K., Perry, N., Fallowfield, L., Jenkins, V., Gold, R., Taylor, A., Gabe, R., Wiggins, J., Lucasse Tags: Open access Cancer genetics Source Type: research